Where Chemistry Meets Efficiency
Our Delivery Solutions
Unlocking the Future of Delivery:
Shaping Tomorrow with LDS's Advanced Formulations - Projects and Collaborations
LDS, a leading biotech company, specializes in revolutionary drug delivery technology for pharmaceuticals, nutraceuticals, and cosmeceuticals.
Our innovative and proprietary delivery system, developed through years of extensive research, offers solutions for insoluble and poorly permeable active molecules, enhancing their bioavailability and efficacy.
The platform technology can be tailored to a wide range of molecules—both small and large, generic or innovative—and customized for various routes of administration, including oral, ocular, dermal, parenteral, nasal, and more.
With a comprehensive patent portfolio of over 37 granted patents, we’ve established global partnerships, collaborated on commercial products, and advanced multiple clinical studies.
LDS welcomes collaboration with industry leaders, innovators, and researchers, offering unparalleled access to our groundbreaking delivery technology.
Pioneering Across Several Healthcare Areas
Our delivery technology has a strong presence in several key healthcare areas, including pharmaceuticals, nutraceuticals, and cosmeceuticals. We are dedicated to advancing the science of drug delivery by continuously evolving our portfolio with specialized, platform-based technologies designed for a broad spectrum of both innovative and generic molecules, large and small.
Pharmaceuticals
Nutraceuticals
Cosmeceuticals
Tailor-Made Delivery Systems for Active Molecules
LDS’s delivery technology utilizes safe, non-toxic, FDA-IIG-approved excipients, designed for tailored compositions to achieve specific delivery objectives, such as enhanced, controlled, or triggered release.
Our developments are meticulously designed and engineered, based on our platform technology, to cater to a wide range of active molecules—whether small or large, soluble or insoluble, innovative or generic.
This approach significantly enhances the bioavailability, stability, and extended shelf-life of active molecules.
The technology is not only cost-effective but also scalable and highly customizable.
Wide Range of Solutions for Multiple
Applications
LDS’s molecularly engineered liquid-structured nano-domains are platform technology designed for numerous applications, various dosages, and different administration routes.
Oral
LDS’s projects are based on the embedment of generic or innovative bio-actives (APIs) designed and prepared to achieve enhanced bioavailability for oral uptake. The active molecules are safeguarded from the harsh conditions of the gastrointestinal (GI) tract, improving their release, absorption, and transport to the bloodstream.
Ophthalmic
LDS’s unique liquid nano-domains provide extensive surface contact with the eye’s epithelium, demonstrating increased stability against the pH and electrolyte levels of the tear film. This enables enhanced permeation to both anterior and posterior eye segments.
Topical and Transdermal
LDS introduces groundbreaking novel topical delivery systems with nano-liquid structures in soft gels or thin films. These enable superior transport of insoluble active molecules (APIs) to the skin layers (epidermis/dermis) and nails, targeting skin diseases, as well as transdermal delivery for high absorption
Parenteral
LDS liquid domains are specially engineered to significantly improve traditional emulsion and suspension formulations in parenteral applications, enhancing chemical, physical, and microbiological stability.
Prof. Nissim Garti
Founder and Chief Scientists
“Our advanced and revolutionary concepts, derived from theoretical calculations and a deep understanding of colloidal science, allow us to design “liquid molecular nano-architectures” that increase stability and enhance the performance of various active molecules and applications in the pharmaceutical and healthcare industries.”
